Clinical Trial Update: Reducing Risk of Diabetic Ketoacidosis in Type 1 Diabetes and Kidney Disease Using Continuous Ketone Monitoring [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from HealthPartners Institute aims to reduce the risk of diabetic ketoacidosis in individuals with Type 1 Diabetes Mellitus and Chronic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 1 Diabetes Mellitus

Snippet

Sponsor: HealthPartners Institute | Conditions: Type 1 Diabetes Mellitus, Chronic Kidney Disease (CKD) With Diabetes Mellitus (DM) | Phase 2 | Status: NOT_YET_RECRUITING